Please use this identifier to cite or link to this item:
|Title:||Patient outcomes on biomarkers after community pharmacist intervention|
Azzopardi, Lilian M.
|Keywords:||Chronic diseases -- Chemotherapy|
Chronically ill -- Care -- Malta -- Case studies
Pharmacist and patient -- Malta
Patient monitoring -- Malta
|Publisher:||University of Malta. Department of Pharmacy|
|Citation:||Muscat, M., Grech, L., & Azzopardi, L. M. (2017, September). Patient outcomes on biomarkers after community pharmacist intervention. Poster session presented at the FIP Annual Conference, Seoul, Republic of Korea.|
|Abstract:||A poster presentation regarding patient outcomes on biomarkers after community pharmacist intervention. Introduction: Chronic diseases present a number of challenges on healthcare systems worldwide. In Malta, community pharmacists are in an optimal position to follow up patients with chronic conditions since patients register with a pharmacy of their choice. Pharmacists can participate more actively in chronic disease care through patient monitoring and medication management. Aim: To evaluate the impact of a pharmacist-led chronic disease management service within a community pharmacy setting. The objectives were to identify the occurrence of drug-related problems (DRPs) in patients with chronic conditions and assess the pharmacist intervention on patient health outcomes.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|Patient_outcomes_on_biomarkers_after_community_pharmacist_intervention_2017.pdf||847.03 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.